全文获取类型
收费全文 | 2753篇 |
免费 | 238篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 57篇 |
妇产科学 | 27篇 |
基础医学 | 414篇 |
口腔科学 | 27篇 |
临床医学 | 211篇 |
内科学 | 685篇 |
皮肤病学 | 68篇 |
神经病学 | 274篇 |
特种医学 | 89篇 |
外科学 | 428篇 |
综合类 | 6篇 |
一般理论 | 3篇 |
预防医学 | 153篇 |
眼科学 | 69篇 |
药学 | 188篇 |
中国医学 | 3篇 |
肿瘤学 | 242篇 |
出版年
2024年 | 4篇 |
2023年 | 31篇 |
2022年 | 33篇 |
2021年 | 87篇 |
2020年 | 57篇 |
2019年 | 125篇 |
2018年 | 137篇 |
2017年 | 83篇 |
2016年 | 87篇 |
2015年 | 95篇 |
2014年 | 124篇 |
2013年 | 155篇 |
2012年 | 245篇 |
2011年 | 222篇 |
2010年 | 147篇 |
2009年 | 98篇 |
2008年 | 184篇 |
2007年 | 174篇 |
2006年 | 153篇 |
2005年 | 137篇 |
2004年 | 120篇 |
2003年 | 107篇 |
2002年 | 101篇 |
2001年 | 32篇 |
2000年 | 38篇 |
1999年 | 20篇 |
1998年 | 12篇 |
1997年 | 16篇 |
1996年 | 9篇 |
1995年 | 9篇 |
1994年 | 7篇 |
1993年 | 5篇 |
1992年 | 9篇 |
1991年 | 11篇 |
1990年 | 8篇 |
1989年 | 6篇 |
1988年 | 12篇 |
1987年 | 10篇 |
1986年 | 8篇 |
1985年 | 9篇 |
1984年 | 9篇 |
1983年 | 8篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1976年 | 5篇 |
1975年 | 3篇 |
1974年 | 6篇 |
1973年 | 7篇 |
排序方式: 共有2999条查询结果,搜索用时 15 毫秒
21.
Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility. 总被引:1,自引:0,他引:1
Robert T Sarisky Paul Crosson Rachel Cano Matthew R Quail Tammy T Nguyen Robert J Wittrock Teresa H Bacon Stephen L Sacks Laure Caspers-Velu Richard L Hodinka Jeffry J Leary 《Journal of clinical virology》2002,23(3):191-200
BACKGROUND: A number of in vitro assays are used to determine susceptibility of HSV to antiviral agents, but results from these in vitro assays do not necessarily correlate with treatment outcome. OBJECTIVES: A method with improved capability for identifying an isolate as acyclovir (ACV) or penciclovir (PCV) resistant when resistance is borderline could greatly improve the management of HSV disease. STUDY DESIGN: A comparative evaluation of four in vitro assays, plaque reduction (PRA), DNA hybridization, plating efficiency (PEA) and plaque autoradiography (PAR) was performed to accurately identify and measure resistance of a TK-altered clinical HSV isolate (HSV-1 N4) from a patient who was non-responsive to ACV treatment. Two established criteria for the prediction of antiviral resistance, IC(50)> or =2.0 microg/ml or an IC(50) greater than 10x above a sensitive virus IC(50), as well as testing in human (MRC-5) and nonhuman (Vero and CV-1 monkey kidney) cell lines were evaluated. RESULTS: The PRA and DNA hybridization assays accurately identified HSV-1 N4 as ACV(r) in human cells when using the 10x above sensitive virus IC(50) resistance criterion. Moreover, the PEA and PAR assays failed to classify HSV-1 N4 as drug resistant and indicate that these technologies alone are inadequate for identifying resistant virus. CONCLUSIONS: The data presented herein indicate that the PRA and DNA hybridization assays most accurately identified an otherwise borderline-resistant isolate as drug resistant: (i) when a sensitive virus is used within each individual assay as a control, (ii) when ACV and PCV susceptibility is evaluated in human cells, and (iii) when the 10x above sensitive IC(50) criterion is used to classify a virus as drug-resistant. Testing of additional clinical samples is warranted to further confirm these findings. 相似文献
22.
UV-light-induced signal cascades and skin aging 总被引:12,自引:0,他引:12
23.
The specific capsular polysaccharide of type 46 Streptococcus pneumoniae (American type 73) was isolated in pure form and shown to be a high-molecular-weight, glycosidically linked polymer composed of d-galactose (2 mol), N-acetyl-d-glucosamine (1 mol), N-acetyl-d-galactosamine (1 mol), and N-acetyl-l-fucosamine (1 mol). 相似文献
24.
Laure F. Pittet Marc Tebruegge Binita Dutta Susan Donath Nicole Messina Dan Casalaz Willem A. Hanekom Warwick J. Britton Roy Robins-Browne Nigel Curtis Nicole Ritz 《Vaccine》2021,39(4):652-657
BackgroundBacillus Calmette–Guérin (BCG) vaccine provides partial protection against Buruli ulcer caused by Mycobacterium ulcerans in epidemiological studies. This study aimed to quantify M. ulcerans-specific immune responses induced by BCG immunisation.MethodsIntracellular cytokine analysis of in-vitro experiments done 10 weeks after BCG immunisation in 130 Australian infants randomised to one of three BCG vaccine strains given either at birth (BCG-Denmark, BCG-Japan, or BCG-Russia) or at two months of age (BCG-Denmark).ResultsProportions of polyfunctional CD4+ T-cells were higher in M. ulcerans-stimulated compared to unstimulated control samples. These proportions were not influenced by the vaccine strain or timing of the immunisation. The M. ulcerans-specific immune responses showed similar patterns to those observed in M. tuberculosis-stimulated samples, although they were of lower magnitude.ConclusionsOur data show that BCG immunisation induces M. ulcerans-specific immune responses in infants, likely explaining the cross-protective effect observed in epidemiological studies. (ACTRN12608000227392) 相似文献
25.
26.
27.
IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. 总被引:2,自引:0,他引:2
Sabina Rinaldi Paolo Toniolo Paola Muti Eva Lundin Anne Zeleniuch-Jacquotte Alan Arslan Andrea Micheli Per Lenner Laure Dossus Vittorio Krogh Roy E Shore Karen L Koenig Elio Riboli P?r Stattin Franco Berrino G?ran Hallmans Annekatrin Lukanova Rudolf Kaaks 《European journal of cancer prevention》2005,14(6):493-496
Prospective cohort studies on breast cancer risk among premenopausal women and insulin-like growth factor I (IGF-I) concentrations have so far included only few cases, and have shown inconsistent relative risk estimates. We pooled 220 cases of breast cancer diagnosed before age 50, and 434 control subjects, from three prospective studies in New York (USA), Ume? (Northern Sweden) and Milan (Italy), and we measured IGF-I and insulin-like growth factor binding protein 3 (IGFBP-3) with common enzyme-linked immunosorbent assays. Overall, IGF-I and IGFBP-3 measurements obtained by the common method showed a positive but not significant relationship with breast cancer risk (odds ratios (ORs) 0.90 [95% confidence intervals (95% CI) 0.50-1.62], 1.63 [0.89-2.97], 1.46 [0.78-2.73] and 1.41 [0.75-2.63] for quintiles of IGF-I, and ORs 0.98 [0.54-1.75], 1.06 [0.59-1.91], 1.04 [0.58-1.87] and 1.77 [0.97-3.24] for quintiles of IGFBP-3). Our results give only moderate support for an association of blood IGF-I with breast cancer risk in young women. 相似文献
28.
Histological long‐term outcomes from acute antibody‐mediated rejection following ABO‐compatible liver transplantation 下载免费PDF全文
29.